Cargando…

The roles of inflammation and immune mechanisms in Alzheimer's disease

The Alzheimer's Association's Research roundtable met in April 2015 to explore the role of neuroinflammatory mechanisms in the progression of Alzheimer's disease (AD). The ability of innate immune cells, particularly microglia and astrocytes, to mediate neuroinflammation in AD has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Eldik, Linda J., Carrillo, Maria C., Cole, Patricia E., Feuerbach, Dominik, Greenberg, Barry D., Hendrix, James A., Kennedy, Matthew, Kozauer, Nick, Margolin, Richard A., Molinuevo, José L., Mueller, Reinhold, Ransohoff, Richard M., Wilcock, Donna M., Bain, Lisa, Bales, Kelly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644267/ https://www.ncbi.nlm.nih.gov/pubmed/29067297 http://dx.doi.org/10.1016/j.trci.2016.05.001

Ejemplares similares

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

A Changing Perspective on the Role of Neuroinflammation in Alzheimer's Disease
por: Wilcock, Donna M.
Publicado: (2012)

Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
por: Wilcock, Donna M.
Publicado: (2012)

Infectious hypothesis of Alzheimer disease
por: Seaks, Charles E., et al.
Publicado: (2020)

Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis
por: Wilcock, Donna M, et al.
Publicado: (2013)

The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
por: Kloske, Courtney M., et al.
Publicado: (2020)

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer’s disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Sex-based differences in effector cells of the adaptive immune system during Alzheimer’s disease and related dementias
por: Lutshumba, Jenny, et al.
Publicado: (2023)

Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank
por: Vitek, Michael P., et al.
Publicado: (2021)

Modulatory effects of α7 nAChRs on the immune system and its relevance for CNS disorders
por: Kalkman, Hans O., et al.
Publicado: (2016)

Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders
por: Kalkman, Hans O., et al.
Publicado: (2017)

Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
por: Atri, Alireza, et al.
Publicado: (2015)

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia
por: Braun, David J., et al.
Publicado: (2019)

Recent Alzheimer's disease research highlights
por: Galasko, Douglas, et al.
Publicado: (2012)

Advancing combination therapy for Alzheimer's disease
por: Salloway, Stephen P., et al.
Publicado: (2020)

Translocator protein in late stage Alzheimer’s disease and Dementia with Lewy bodies brains
por: Xu, Jinbin, et al.
Publicado: (2019)

A meditation on medications, among other things
por: Ransohoff, Richard M.
Publicado: (2014)

Gathering thunder
por: Ransohoff, Richard M.
Publicado: (2014)

Informing and inspiring
por: Ransohoff, Richard M.
Publicado: (2014)

Meet the new team!
por: Ransohoff, Richard M.
Publicado: (2014)

All (animal) models (of neurodegeneration) are wrong. Are they also useful?
por: Ransohoff, Richard M.
Publicado: (2018)

Animal models of multiple sclerosis: the good, the bad and the bottom line
por: Ransohoff, Richard M
Publicado: (2012)

Welcome to Alzheimer's Research & Therapy
por: Donnelly, Ann, et al.
Publicado: (2009)

Plasma TDP‐43 levels are associated with neuroimaging measures of brain structure in limbic regions
por: Bauer, Christopher E., et al.
Publicado: (2023)

Psychiatric manifestations of neurologic disease: where are we headed?
por: Lyketsos, Constantin G., et al.
Publicado: (2007)

Alzheimer's & Dementia—Translational Research and Clinical Interventions: Strategic vision and expanded guidelines for manuscript submissions
por: Greenberg, Barry D.
Publicado: (2022)

In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
por: Braun, David J., et al.
Publicado: (2018)

Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis
por: Ransohoff, Richard M., et al.
Publicado: (2000)

Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
por: Limatola, Cristina, et al.
Publicado: (2014)

Editorial Research Topic “Chemokines and chemokine receptors in brain homeostasis”
por: Ransohoff, Richard M., et al.
Publicado: (2015)

GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2017)

Crosstalk Between Astrocytes and Microglia: An Overview
por: Matejuk, Agata, et al.
Publicado: (2020)

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2019)

Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses
por: Wilcock, Donna M, et al.
Publicado: (2011)

Alzheimer’s disease prevention: from risk factors to early intervention
por: Crous-Bou, Marta, et al.
Publicado: (2017)

Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals(2)
por: Milne, Richard, et al.
Publicado: (2018)

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
por: Craig-Schapiro, Rebecca, et al.
Publicado: (2011)

Nature killer cells in the central nervous system
por: Shi, Fu-Dong, et al.
Publicado: (2010)

Formal reply to “Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX”
por: Feuerbach, Lars
Publicado: (2021)

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
por: Gold, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u28vespbvdnskd9snlbtavdlhp